Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832622 · ClinicalTrials.gov registry record
MultiPoint Pacing™ Post Market Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 2,169
- Enrollment target
NCT02832622 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 2,169 participants.
The verdict
NCT02832622 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 2,169 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 140 centers undergoing CRT implantation.
Interventions
- DEVICE MPP
- DEVICE BiV/MPP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,169 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02832622
The ClinicalTrials.gov registry entry for NCT02832622 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MPP is the first listed.
NCT02832622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02832622 about?
NCT02832622 is a clinical study titled "MultiPoint Pacing™ Post Market Study". This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 140 centers undergoing CRT implantation.
What is the current status of trial NCT02832622?
This trial is currently completed. The enrollment target is 2,169 participants. The study started on 2016-07. Estimated completion is 2019-07-15.
What interventions are being tested in trial NCT02832622?
The interventions under investigation include: MPP (DEVICE), BiV/MPP (DEVICE).
Who is sponsoring clinical trial NCT02832622?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.